ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $825,000 | +88135.3% | 275,000 | +10.0% | 0.88% | -4.1% |
| Q2 2023 | $935 | -14.1% | 250,000 | -23.1% | 0.91% | -29.5% |
| Q1 2023 | $1,089 | -17.7% | 325,000 | +18.2% | 1.29% | -18.2% |
| Q4 2022 | $1,323 | -99.9% | 275,000 | +10.0% | 1.58% | -0.5% |
| Q3 2022 | $1,423,000 | +0.2% | 250,000 | +25.0% | 1.59% | +5.1% |
| Q2 2022 | $1,420,000 | -1.7% | 200,000 | 0.0% | 1.51% | +24.7% |
| Q1 2022 | $1,444,000 | +61.5% | 200,000 | +100.0% | 1.21% | +79.6% |
| Q4 2021 | $894,000 | -74.5% | 100,000 | 0.0% | 0.68% | -74.2% |
| Q3 2021 | $3,506,000 | +81.4% | 100,000 | +11.1% | 2.62% | +87.2% |
| Q2 2021 | $1,933,000 | – | 90,000 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |